Colorimetric sandwich immunosensor for Aβ(1-42) based on dual antibody-modified gold nanoparticles

[1]  Xiurong Yang,et al.  Antibody modified-silver nanoparticles for colorimetric immuno sensing of Aβ(1–40/1–42) based on the interaction between β-amyloid and Cu2+ , 2016 .

[2]  Arti Vashist,et al.  Nano-biosensors to detect beta-amyloid for Alzheimer's disease management. , 2016, Biosensors & bioelectronics.

[3]  Sadia Afrin Khan,et al.  Rapid and sensitive detection of cholera toxin using gold nanoparticle-based simple colorimetric and dynamic light scattering assay. , 2015, Analytica chimica acta.

[4]  Wei Wei,et al.  Colorimetric detection of influenza A virus using antibody-functionalized gold nanoparticles. , 2015, The Analyst.

[5]  Karl Herrup,et al.  The case for rejecting the amyloid cascade hypothesis , 2015, Nature Neuroscience.

[6]  Yao-Wu Liu,et al.  A sensitive colorimetric strategy for monitoring cerebral β-amyloid peptides in AD based on dual-functionalized gold nanoplasmonic particles. , 2015, Chemical communications.

[7]  Yanli Zhou,et al.  Simple Colorimetric Detection of Amyloid β-peptide (1-40) based on Aggregation of Gold Nanoparticles in the Presence of Copper Ions. , 2015, Small.

[8]  A. Fagan,et al.  Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective. , 2015, Advances in medical sciences.

[9]  X. Qu,et al.  New insights in amyloid beta interactions with human telomerase. , 2015, Journal of the American Chemical Society.

[10]  Zhiyuan Hu,et al.  Label-free detection of Alzheimer's disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide. , 2015, Chemical communications.

[11]  G. Shi,et al.  A method for evaluating the level of soluble β-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to β-amyloid peptides. , 2014, Angewandte Chemie.

[12]  B. Winblad,et al.  Simultaneous imaging of amyloid-β and lipids in brain tissue using antibody-coupled liposomes and time-of-flight secondary ion mass spectrometry. , 2014, Journal of the American Chemical Society.

[13]  E. Scarpini,et al.  Detection of misfolded Aβ oligomers for sensitive biochemical diagnosis of Alzheimer's disease. , 2014, Cell reports.

[14]  Blaine R. Roberts,et al.  Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes. , 2013, Biomarkers in medicine.

[15]  S. Ko,et al.  Colorimetric assay of matrix metalloproteinase activity based on metal-induced self-assembly of carboxy gold nanoparticles. , 2013, Biosensors & bioelectronics.

[16]  M. Verbeek,et al.  Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue. , 2013, Analytical biochemistry.

[17]  E. Dufour-Gergam,et al.  A new controlled concept of immune-sensing platform for specific detection of Alzheimer's biomarkers. , 2013, Biosensors & bioelectronics.

[18]  Zhenxin Wang,et al.  Gold nanoparticle based dot-blot immunoassay for sensitively detecting Alzheimer's disease related β-amyloid peptide. , 2012, Chemical communications.

[19]  J. Cirrito,et al.  Microbiosensor for Alzheimer’s disease diagnostics: detection of amyloid beta biomarkers , 2012, Journal of neurochemistry.

[20]  Sarit S. Agasti,et al.  Gold nanoparticles in chemical and biological sensing. , 2012, Chemical reviews.

[21]  L. Mucke,et al.  Alzheimer Mechanisms and Therapeutic Strategies , 2012, Cell.

[22]  W. Xu,et al.  Association Study of Clusterin Polymorphism rs11136000 With Late Onset Alzheimer’s Disease in Chinese Han Population , 2011, American journal of Alzheimer's disease and other dementias.

[23]  Yong Wang,et al.  Aptamer-based colorimetric biosensing of dopamine using unmodified gold nanoparticles , 2011 .

[24]  Zhenxin Wang,et al.  Resonance light scattering as a powerful tool for sensitive detection of β-amyloid peptide by gold nanoparticle probes. , 2011, Chemical communications.

[25]  R. Tripp,et al.  One-step assay for detecting influenza virus using dynamic light scattering and gold nanoparticles. , 2011, The Analyst.

[26]  Xiurong Yang,et al.  Label-free colorimetric immunoassay for the simple and sensitive detection of neurogenin3 using gold nanoparticles. , 2011, Biosensors & bioelectronics.

[27]  X. Qu,et al.  Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease. , 2011, Angewandte Chemie.

[28]  Su Jin Lee,et al.  A novel colorimetric aptasensor using gold nanoparticle for a highly sensitive and specific detection of oxytetracycline. , 2010, Biosensors & bioelectronics.

[29]  Ning Xia,et al.  Regenerable and simultaneous surface plasmon resonance detection of aβ(1-40) and aβ(1-42) peptides in cerebrospinal fluids with signal amplification by streptavidin conjugated to an N-terminus-specific antibody. , 2010, Analytical chemistry.

[30]  Amber D. Wellman,et al.  Analysis of monomeric Abeta (1-40) peptide by capillary electrophoresis. , 2010, The Analyst.

[31]  M. Weiner,et al.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.

[32]  Fan Yang,et al.  Label-free colorimetric detection of small molecules utilizing DNA oligonucleotides and silver nanoparticles. , 2009, Small.

[33]  A. Rauk.  The chemistry of Alzheimer's disease. , 2009, Chemical Society reviews.

[34]  Xiangqun Zeng,et al.  Single chain fragment variable recombinant antibody functionalized gold nanoparticles for a highly sensitive colorimetric immunoassay. , 2009, Biosensors & bioelectronics.

[35]  E. Tamiya,et al.  Amyloid-beta detection with saccharide immobilized gold nanoparticle on carbon electrode. , 2008, Bioelectrochemistry.

[36]  Michael A. Brook,et al.  Design of Gold Nanoparticle‐Based Colorimetric Biosensing Assays , 2008, Chembiochem : a European journal of chemical biology.

[37]  H. Fukuyama,et al.  Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease , 2008, Proceedings of the National Academy of Sciences.

[38]  Hui Chen,et al.  A one-step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. , 2008, Journal of the American Chemical Society.

[39]  D. Selkoe,et al.  Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide , 2007, Nature Reviews Molecular Cell Biology.

[40]  Mun'delanji C. Vestergaard,et al.  A rapid label-free electrochemical detection and kinetic study of Alzheimer's amyloid beta aggregation. , 2005, Journal of the American Chemical Society.

[41]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[42]  S. Younkin,et al.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.

[43]  D. Selkoe,et al.  Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production , 1992, Nature.

[44]  L. Tan,et al.  Biomarkers for preclinical Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[45]  G. Böhm,et al.  Detection of Amyloid-β Oligomers in Human Cerebrospinal Fluid by Flow Cytometry and Fluorescence Resonance Energy Transfer , 2007 .

[46]  Chad A Mirkin,et al.  The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange , 2006, Nature Protocols.